Journals / İzmir Tepecik Eğitim Hastanesi Dergisi / 2022 / Cilt: 32 - Sayı: 1

A Case of Pilomatricoma Associated with Neurofibromatosis Type 2 in Childhood

Çocukluk Çağında Pilomatrikomanın Eşlik Ettiği Nörofibromatozis Tip 2 Olgusu

Pages
151–154
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We reported a case of NF2 presented with peripheral Schwannoma associated with scalp-located pilomatrixoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neurofibromatosis type 1 is the most common neurocutaneous syndrome, however neurofibromatosis type 2 (NF2) is extremely rare in childhood.
📊
Key Findings & Data:It is caused by a mutation of a tumor suppressor gene located on the chromosome 22.
💡
Conclusion & Impact:We reported a case of NF2 presented with peripheral Schwannoma associated with scalp-located pilomatrixoma.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Neurofibromatosis type 1 is the most common neurocutaneous syndrome, however neurofibromatosis type 2 (NF2) is extremely rare in childhood. It is inherited as autosomal dominant. Spontaneous mutation is detected in half of the cases and there is no family history. It is caused by a mutation of a tumor suppressor gene located on the chromosome 22. NF2 affected individuals also have a much higher rate of cancer. For the diagnosis, Manchester diagnostic criteria are used: Bilateral vestibular Schwannoma (VS) or family history of NF2 plus unilateral VS or any two of meningioma, glioma, neurofibroma, Schwannoma, posterior subcapsular lenticular opacities. We reported a case of NF2 presented with peripheral Schwannoma associated with scalp-located pilomatrixoma.

Özet

Nörofibromatozis tip 1 çocukluk çağında en sık görülen nörokutan sendrom iken nörofibromatozis tip 2 (NF2) oldukça nadirdir. Otozomal dominant kalıtılır. Olguların yarısında spontan mutasyon saptanır ve aile öyküsü yoktur. 22. kromozomda bulunan tümör supresör gendeki mutasyon sonucunda oluşur. NF2’den etkilenen bireyler, daha yüksek bir oranda kanser riskine sahiptir. Tanı için Manchester tanı kriterleri kullanılır: Bilateral vestibular Schwannoma (VS) veya birinci derece akrabalarda NF2 öyküsüne ek olarak unilateral VS veya menenjiyom, Schwannom ve posterior subkapsüler katarakt gibi bulgulardan en az ikisinin birlikteliği ile konur. Kafa derisi yerleşimli pilomatriksoma ile beraber periferik Schwannom’u olan bir NF2 olgusunu sunduk.

🔖

Cite This Article

KIZMAZOĞLU, D., GENÇPINAR, P. (2022). A Case of Pilomatricoma Associated with Neurofibromatosis Type 2 in Childhood. İzmir Tepecik Eğitim Hastanesi Dergisi, Cilt: 32 - Sayı: 1, 151–154. https://ajindex.com/articles/558023

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (19)

  1. Asthagiri AR, Parry DM, Butman JA, et al. Neurofibromatosis Type 2. Lancet 2009;373:1974-86
  2. Ardern-Holmes S, Fisher G, North K. Neurofibromatosis Type 2. J Child Neurol 2017;32:9-22
  3. Evans DG, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet 1992;29:847-52
  4. Anand G, Vasollo G, Spanou M, et al. Diagnosis of sporadic Neurofibromatosis type 2 in the paediatric population. Arch Dis Child 2018;103:463-9
  5. Yohay KH. The genetic and molecular pathogenesis of NF1 and NF2. Semin Pediatr Neurol 2006;13:21-6
  6. Ferner RE. Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective. Lancet Neurol 2007;6:340-51
  7. Ciriacks K, Knabel D, Waite MB. Syndromes associated with multiple pilomatricomas: When should clinicians be concerned? Pediatr Dermatol 2020;37:9-17
  8. Nunes F, MacCollin M. Neurofibromatosis 2 in the pediatrik population. J Child Neurol 2003;18:718-24
  9. Brackmann DE, Fayad JN, Slattery WH 3rd, et al. Early proactive management of vestibular schwannomas in neurofibromatosis type 2. Neurosurgery 2001;49:274-80
  10. Hoffman RA, Kohan D, Cohen NL. Cochlear implants in the management of bilateral acoustic neuromas. Am J Otol 1992;13:525-8
  11. North HJD, Lloyd SKW. Hearing rehabilition in Neurofibromatosis Type 2. Adv Otorhinolaryngol 2018;81:93-104
  12. Baser ME, Friedman JM, Aeschliman D, et al. Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet 2002;71:715-23
  13. Halliday D, Parry A, Evans DG. Neurofibromatosis type 2 and related disorders. Curr Opin Oncol 2019;31:562-7
  14. Kaye LD, Rothner AD, Beauchamp GR, Meyers SM, Estes ML. Ocular findings associated with neurofibromatosis Type II. IOphthalmology 1992;99:1424-9
  15. Reddy AT, Hedlund GL, Percy AK. Enlarged parietal foramina: association with cerebral venous and cortical anomalies. Neurology 2000;54:1175-8
  16. Mupparapu M, Binder RE, Duarte F. Hereditary cranium bifidum persisting as enlarged parietal foramina (Catlin marks) on cephalometric radiographs. Am J Orthod Dentofacial Orthop 2006;129:825-8
  17. Mautner VF, Lindenau M, Baser ME, Kluwe L, Gottschalk J. Skin abnormalities in neurofibromatosis 2. Arch Dermatol 1997;133:1539-43
  18. Cecen E, Ozguven AA, Uysal KM, et al. Pilomatricoma in children: a frequently misdiagnosed superficial tumor. Pediatr Hematol Oncol 2008;25:522-7
  19. Bittmann S, Ulus H. Concomitant pilomatrixoma and periphera